Advertisement
Screener

REVVITY, INC (RVTY) Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements

2.8 / 5 stars · 68/120 Roast Me

REVVITY, INC Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements

REVVITY, INC (RVTY) reported Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements of $11.19 million for the 3-month period ending 2026-07-05, per its 10-Q filed 2026-08-11.

Financial Statements › Notes › Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation › Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Purchases, (Sales), Issuances, (Settlements)

us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements · last filed 2026-08-11

  • REVVITY, INC fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, settlements for the quarter ending 2026-07-05 was $11.19M.
  • REVVITY, INC fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, settlements for the quarter ending 2026-04-05 was $759.00K, a 45.32% decline year-over-year.
  • REVVITY, INC fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, settlements for the quarter ending 2025-12-28 was -$54.00K, a 103.70% decline year-over-year.
  • REVVITY, INC fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, settlements for the quarter ending 2025-09-28 was $2.04M.
  • REVVITY, INC fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, settlements for fiscal 2025 was $2.48M, a 84.84% decline from fiscal 2024.
  • REVVITY, INC fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, settlements for fiscal 2024 was $16.38M, a 68.19% increase from fiscal 2023.
  • REVVITY, INC fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, settlements for fiscal 2023 was $9.74M, a 280.21% increase from fiscal 2023.
  • REVVITY, INC fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, settlements for fiscal 2023 was $2.56M, a 53.48% decline from fiscal 2022.
Period endFair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements 3 monthFair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements 3 month as first filedFair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements 6 monthFair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements 6 month as first filedFair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements 9 monthFair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements 9 month as first filedFair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements 12 monthFair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements 12 month as first filed
2026-07-05$11.19M
10-Q · filed 2026-08-11
$11.95M
10-Q · filed 2026-08-11
$11.90M
derived: sum of 3 quarters · filed 2026-08-11
$13.94M
derived: sum of 4 quarters · filed 2026-08-11
2026-04-05$759.00K
10-Q · filed 2026-05-12
$705.00K
derived: sum of 2 quarters · filed 2026-05-12
$2.75M
derived: sum of 3 quarters · filed 2026-05-12
$1.85M
derived: sum of 4 quarters · filed 2026-08-11
2025-12-28-$54.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24
$1.99M
derived: sum of 2 quarters · filed 2026-02-24
$1.10M
derived: sum of 3 quarters · filed 2026-08-11
$2.48M
10-K · filed 2026-02-24
2025-09-28$2.04M
10-Q · filed 2025-11-04
$1.15M
derived: sum of 2 quarters · filed 2026-08-11
$2.54M
10-Q · filed 2025-11-04
$4.00M
derived: sum of 4 quarters · filed 2026-08-11
2025-06-29-$891.00K
10-Q · filed 2026-08-11
$497.00K
10-Q · filed 2026-08-11
$1.96M
derived: sum of 3 quarters · filed 2026-08-11
$1.07M
derived: sum of 4 quarters · filed 2026-08-11
2025-03-30$1.39M
10-Q · filed 2026-05-12
$2.85M
derived: sum of 2 quarters · filed 2026-05-12
$1.96M
derived: sum of 3 quarters · filed 2026-05-12
$2.11M
derived: sum of 4 quarters · filed 2026-05-12
2024-12-29$1.46M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24
$569.00K
derived: sum of 2 quarters · filed 2026-02-24
$721.00K
derived: sum of 3 quarters · filed 2026-02-24
$16.38M
10-K · filed 2026-02-24
2024-09-29-$889.00K
10-Q · filed 2025-11-04
-$737.00K
derived: sum of 2 quarters · filed 2025-11-04
$14.93M
10-Q · filed 2025-11-04
$13.71M
derived: sum of 4 quarters · filed 2026-02-24
2024-06-30$152.00K
10-Q · filed 2025-08-05
$15.81M
10-Q · filed 2025-08-05
$14.60M
derived: sum of 3 quarters · filed 2026-02-24
$15.41M
derived: sum of 4 quarters · filed 2026-02-24
2024-03-31$15.66M
10-Q · filed 2025-05-06
$14.44M
derived: sum of 2 quarters · filed 2026-02-24
$15.26M
derived: sum of 3 quarters · filed 2026-02-24
$23.98M
derived: sum of 4 quarters · filed 2026-02-24
2023-12-31-$1.22M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24
-$401.00K
derived: sum of 2 quarters · filed 2026-02-24
$8.32M
derived: sum of 3 quarters · filed 2026-02-24
$9.74M
10-K · filed 2026-02-24
2023-10-01$817.00K
10-Q · filed 2024-11-06
$9.54M
derived: sum of 2 quarters · filed 2024-11-06
$10.96M
10-Q · filed 2024-11-06
$8.31M
derived: sum of 4 quarters · filed 2025-02-25
2023-07-02$8.72M
10-Q · filed 2024-08-06
$10.14M
10-Q · filed 2024-08-06
$7.49M
derived: sum of 3 quarters · filed 2025-02-25
$9.38M
derived: sum of 4 quarters · filed 2025-02-25
2023-04-02$1.42M
10-Q · filed 2024-05-07
-$1.23M
derived: sum of 2 quarters · filed 2025-02-25
$660.00K
derived: sum of 3 quarters · filed 2025-02-25
$2.56M
derived: sum of 4 quarters · filed 2025-02-25
2023-01-01-$2.65M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25
-$764.00K
derived: sum of 2 quarters · filed 2025-02-25
$1.14M
derived: sum of 3 quarters · filed 2025-02-25
$2.56M
10-K · filed 2025-02-25
2022-10-02$1.89M
10-Q · filed 2023-11-07
$3.79M
derived: sum of 2 quarters · filed 2023-11-07
$5.21M
10-Q · filed 2023-11-07
$10.01M
derived: sum of 4 quarters · filed 2024-02-27
2022-07-03$1.90M
10-Q · filed 2023-08-09
$3.33M
10-Q · filed 2023-08-09
$8.12M
derived: sum of 3 quarters · filed 2024-02-27
$8.74M
derived: sum of 4 quarters · filed 2024-02-27
2022-04-03$1.42M
10-Q · filed 2023-05-12
$6.22M
derived: sum of 2 quarters · filed 2024-02-27
$6.83M
derived: sum of 3 quarters · filed 2024-02-27
$6.86M
derived: sum of 4 quarters · filed 2024-02-27
2022-01-02$4.80M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27
$5.41M
derived: sum of 2 quarters · filed 2024-02-27
$5.44M
derived: sum of 3 quarters · filed 2024-02-27
$5.51M
10-K · filed 2024-02-27
2021-10-03$615.00K
10-Q · filed 2022-11-14
$642.00K
derived: sum of 2 quarters · filed 2022-11-14
$711.00K
10-Q · filed 2022-11-14
$14.25M
derived: sum of 4 quarters · filed 2023-03-01
2021-07-04$27.00K
10-Q · filed 2022-08-09
$96.00K
10-Q · filed 2022-08-09
$13.63M
derived: sum of 3 quarters · filed 2023-03-01
$13.49M
derived: sum of 4 quarters · filed 2023-03-01
2021-04-04$69.00K
10-Q · filed 2022-05-10
$13.61M
derived: sum of 2 quarters · filed 2023-03-01
$13.46M
derived: sum of 3 quarters · filed 2023-03-01
$23.39M
derived: sum of 4 quarters · filed 2023-03-01
2021-01-03$13.54M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01
$13.39M
derived: sum of 2 quarters · filed 2023-03-01
$23.32M
derived: sum of 3 quarters · filed 2023-03-01
$23.70M
10-K · filed 2023-03-01
2020-10-04-$144.00K
10-Q · filed 2021-11-09
$9.79M
derived: sum of 2 quarters · filed 2021-11-09
$10.16M
10-Q · filed 2021-11-09
$12.40M
derived: sum of 4 quarters · filed 2022-03-03
2020-07-05$9.93M
10-Q · filed 2021-08-10
$10.31M
10-Q · filed 2021-08-10
$12.55M
derived: sum of 3 quarters · filed 2022-03-03
$22.54M
derived: sum of 4 quarters · filed 2022-03-03
2020-04-05$379.00K
10-Q · filed 2021-05-11
$2.62M
derived: sum of 2 quarters · filed 2022-03-03
$12.61M
derived: sum of 3 quarters · filed 2022-03-03
$12.76M
derived: sum of 4 quarters · filed 2022-03-03
2019-12-29$2.24M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-03
$12.23M
derived: sum of 2 quarters · filed 2022-03-03
$12.38M
derived: sum of 3 quarters · filed 2022-03-03
$50.80M
10-K · filed 2022-03-03
2019-09-29$10.00M
10-Q · filed 2020-11-10
$10.14M
derived: sum of 2 quarters · filed 2020-11-10
$48.56M
10-Q · filed 2020-11-10
$28.56M
derived: sum of 4 quarters · filed 2021-03-02
2019-06-30$147.00K
10-Q · filed 2020-08-11
$38.56M
10-Q · filed 2020-08-11
$18.56M
derived: sum of 3 quarters · filed 2021-03-02
$35.07M
derived: sum of 4 quarters · filed 2021-03-02
2019-03-31$18.41M
10-Q · filed 2020-05-12
$18.41M
derived: sum of 2 quarters · filed 2021-03-02
$34.92M
derived: sum of 3 quarters · filed 2021-03-02
$34.92M
derived: sum of 4 quarters · filed 2021-03-02
2018-12-30-$1.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-02
$16.51M
derived: sum of 2 quarters · filed 2021-03-02
$16.51M
derived: sum of 3 quarters · filed 2021-03-02
$16.51M
10-K · filed 2021-03-02
$16.51M
10-K · filed 2019-02-26
2018-09-30$16.51M
10-Q · filed 2019-11-05
$16.51M
derived: sum of 2 quarters · filed 2019-11-05
$16.51M
10-Q · filed 2019-11-05
$16.51M
derived: sum of 4 quarters · filed 2020-02-25
2018-07-01$0.00
10-Q · filed 2019-08-06
$0.00
10-Q · filed 2019-08-06
$1.00K
derived: sum of 3 quarters · filed 2020-02-25
$1.00K
derived: sum of 4 quarters · filed 2020-02-25
2018-04-01$0.00
10-Q · filed 2019-05-07
$1.00K
derived: sum of 2 quarters · filed 2020-02-25
$1.00K
derived: sum of 3 quarters · filed 2020-02-25
$1.00K
derived: sum of 4 quarters · filed 2020-02-25
2017-12-31$1.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25
$1.00K
derived: sum of 2 quarters · filed 2020-02-25
$1.00K
derived: sum of 3 quarters · filed 2020-02-25
$35.00K
10-K · filed 2020-02-25
$34.00K
10-K · filed 2018-02-27
2017-10-01$0.00
10-Q · filed 2018-11-06
$0.00
derived: sum of 2 quarters · filed 2018-11-06
$34.00K
10-Q · filed 2018-11-06
$253.00K
derived: sum of 4 quarters · filed 2019-02-26
2017-07-02$0.00
10-Q · filed 2018-08-07
$34.00K
10-Q · filed 2018-08-07
$253.00K
derived: sum of 3 quarters · filed 2019-02-26
$267.00K
derived: sum of 4 quarters · filed 2019-02-26
2017-04-02$34.00K
10-Q · filed 2018-05-08
$253.00K
derived: sum of 2 quarters · filed 2019-02-26
$267.00K
derived: sum of 3 quarters · filed 2019-02-26
$273.00K
derived: sum of 4 quarters · filed 2019-02-26
2017-01-01$219.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26
$233.00K
derived: sum of 2 quarters · filed 2019-02-26
$239.00K
derived: sum of 3 quarters · filed 2019-02-26
$332.00K
10-K · filed 2019-02-26
2016-10-02$14.00K
10-Q · filed 2017-11-07
$20.00K
derived: sum of 2 quarters · filed 2017-11-07
$113.00K
10-Q · filed 2017-11-07
$191.00K
derived: sum of 4 quarters · filed 2018-02-27
2016-07-03$6.00K
10-Q · filed 2017-08-08
$100.00K
10-Q · filed 2017-08-08
$177.00K
derived: sum of 3 quarters · filed 2018-02-27
$203.00K
derived: sum of 4 quarters · filed 2018-02-27
2016-04-03$94.00K
10-Q · filed 2017-05-09
$171.00K
derived: sum of 2 quarters · filed 2018-02-27
$197.00K
derived: sum of 3 quarters · filed 2018-02-27
$197.00K
derived: sum of 4 quarters · filed 2018-02-27
2016-01-03$77.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27
$103.00K
derived: sum of 2 quarters · filed 2018-02-27
$103.00K
derived: sum of 3 quarters · filed 2018-02-27
$113.00K
10-K · filed 2018-02-27
2015-10-04$26.00K
10-Q · filed 2016-11-08
$26.00K
derived: sum of 2 quarters · filed 2016-11-08
$36.00K
10-Q · filed 2016-11-08
$45.00K
derived: sum of 4 quarters · filed 2017-02-28
2015-06-28$0.00
10-Q · filed 2016-08-09
$10.00K
10-Q · filed 2016-08-09
$19.00K
derived: sum of 3 quarters · filed 2017-02-28
$2.16M
derived: sum of 4 quarters · filed 2017-02-28
2015-03-29$10.00K
10-Q · filed 2016-05-10
$19.00K
derived: sum of 2 quarters · filed 2017-02-28
$2.16M
derived: sum of 3 quarters · filed 2017-02-28
$2.08M
derived: sum of 4 quarters · filed 2017-02-28
2014-12-28$9.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-28
$2.15M
derived: sum of 2 quarters · filed 2017-02-28
$2.07M
derived: sum of 3 quarters · filed 2017-02-28
$2.07M
10-K · filed 2017-02-28
-$2.07M
10-K · filed 2015-02-24
2014-09-28$2.14M
10-Q · filed 2015-11-10
$2.06M
derived: sum of 2 quarters · filed 2015-11-10
$2.06M
10-Q · filed 2015-11-10
$2.10M
derived: sum of 4 quarters · filed 2016-03-01
2014-06-29-$72.00K
10-Q · filed 2015-08-04
-$72.00K
10-Q · filed 2015-08-04
$72.00K
10-Q · filed 2014-08-05
-$32.00K
derived: sum of 3 quarters · filed 2016-03-01
-$1.00K
derived: sum of 4 quarters · filed 2016-03-01
2014-03-30$0.00
10-Q · filed 2015-05-05
$40.00K
derived: sum of 2 quarters · filed 2016-03-01
$71.00K
derived: sum of 3 quarters · filed 2016-03-01
$71.00K
derived: sum of 4 quarters · filed 2016-03-01
2013-12-29$40.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-01
$71.00K
derived: sum of 2 quarters · filed 2016-03-01
$71.00K
derived: sum of 3 quarters · filed 2016-03-01
$135.00K
10-K · filed 2016-03-01
-$135.00K
10-K · filed 2014-02-25
2013-09-29$31.00K
10-Q · filed 2014-11-04
-$31.00K
10-Q · filed 2013-11-05
$31.00K
derived: sum of 2 quarters · filed 2014-11-04
$95.00K
10-Q · filed 2014-11-04
-$95.00K
10-Q · filed 2013-11-05
$79.00K
derived: sum of 4 quarters · filed 2015-02-24
2013-06-30$0.00
10-Q · filed 2014-08-05
-$64.00K
10-Q · filed 2014-08-05
$48.00K
derived: sum of 3 quarters · filed 2015-02-24
-$3.72M
derived: sum of 4 quarters · filed 2015-02-24
2013-03-31$64.00K
10-Q · filed 2014-05-06
-$64.00K
10-Q · filed 2013-05-06
$48.00K
derived: sum of 2 quarters · filed 2015-02-24
-$3.72M
derived: sum of 3 quarters · filed 2015-02-24
-$17.37M
derived: sum of 4 quarters · filed 2015-02-24
2012-12-30-$16.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-24
-$3.79M
derived: sum of 2 quarters · filed 2015-02-24
-$17.43M
derived: sum of 3 quarters · filed 2015-02-24
-$17.43M
10-K · filed 2015-02-24
2012-09-30-$3.77M
10-Q · filed 2013-11-05
-$17.42M
derived: sum of 2 quarters · filed 2013-11-05
-$17.42M
10-Q · filed 2013-11-05
-$17.42M
derived: sum of 4 quarters · filed 2014-02-25
2012-07-01-$13.65M
10-Q · filed 2013-08-06
-$13.65M
10-Q · filed 2013-08-06
-$13.65M
derived: sum of 3 quarters · filed 2014-02-25
-$13.65M
derived: sum of 4 quarters · filed 2014-02-25
2012-04-01$0.00
10-Q · filed 2013-05-06
$0.00
derived: sum of 2 quarters · filed 2014-02-25
$0.00
derived: sum of 3 quarters · filed 2014-02-25
$0.00
derived: sum of 4 quarters · filed 2014-02-25
2012-01-01$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-25
$0.00
derived: sum of 2 quarters · filed 2014-02-25
$0.00
derived: sum of 3 quarters · filed 2014-02-25
-$1.91M
10-K · filed 2014-02-25
2011-10-02$0.00
10-Q · filed 2012-11-06
$0.00
derived: sum of 2 quarters · filed 2012-11-06
-$1.91M
10-Q · filed 2012-11-06
-$1.91M
derived: sum of 4 quarters · filed 2013-02-26
2011-07-03$0.00
10-Q · filed 2012-08-07
-$1.91M
10-Q · filed 2012-08-07
-$1.91M
derived: sum of 3 quarters · filed 2013-02-26
-$1.91M
derived: sum of 4 quarters · filed 2013-02-26
2011-04-03-$1.91M
10-Q · filed 2012-05-08
-$1.91M
derived: sum of 2 quarters · filed 2013-02-26
-$1.91M
derived: sum of 3 quarters · filed 2013-02-26
2011-01-02$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-26
$0.00
derived: sum of 2 quarters · filed 2013-02-26
-$2.72M
10-K · filed 2013-02-26
2010-10-03$0.00
10-Q · filed 2011-11-04
-$2.72M
10-Q · filed 2011-11-04
2010-01-03$0.00
10-K · filed 2012-02-28

Similar stocks

Stock NameCountryMarket CapPE Ratio
Avantor, Inc. (AVTR)United States$10.501B-9.72
BRUKER CORP (BRKR)United States$9.706B-128.75
METTLER TOLEDO INTERNATIONAL INC/ (MTD)$30.436B30.62
Alamar Biosciences, Inc. (ALMR)United States$2.300B
Cytek Biosciences, Inc. (CTKB)United States$0.744B-7.15
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB)United States$0.491B-3.95
908 Devices Inc. (MASS)United States$0.476B-9.53
EyePoint, Inc. (EYPT)United States$0.314B-3.96
Quanterix Corp (QTRX)United States$0.150B-1.65
Nautilus Biotechnology, Inc. (NAUT)United States$0.129B-4.16